SLAS Discovery

Papers
(The median citation count of SLAS Discovery is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Fluorescent probe for the identification of potent inhibitors of the macrophage infectivity potentiator (Mip) protein of Burkholderia pseudomallei159
Ex vivo discovery of synergistic drug combinations for hematologic malignancies56
Outline and background for the EU-OS solubility prediction challenge51
POLARISED views and FRETting about probe modulation assays: Learning from High Throughput Screening43
Magnetic 3D bioprinting of skeletal muscle spheroid for a spheroid-based screening assay33
Genetically encoded fluorogenic RNA-based bioluminescence resonance energy transfer (BRET) sensors for cellular imaging and target detection29
FLECS technology for high-throughput screening of hypercontractile cellular phenotypes in fibrosis: A function-first approach to anti-fibrotic drug discovery24
Bioassay protocol metadata annotation: Proposed standards adoption24
Protocol for 3D screening of lung cancer spheroids using natural products22
Standards for reporting optical biosensor experiments (STROBE): Improving standards in the reporting of optical biosensor-based data in the literature21
Time-resolved FRET screening identifies small molecular modifiers of mutant Huntingtin conformational inflexibility in patient-derived cells17
Emerging drug discovery ecosystems16
Nanobodies: A Game-Changer in Cell-Mediated Immunotherapy for Cancer16
HTS driven by fluorescence lifetime detection of FRET identifies activators and inhibitors of cardiac myosin16
Role Of Vaccines Against COVID-19 Pandemic15
An efficient and scalable data analysis solution for automated electrophysiology platforms15
Drug repurposing screen for the rare disease ataxia-telangiectasia15
Parallel in vitro ion channel and in vivo zebrafish assaying of elapid snake venoms following chromatographic separation of toxin components15
Temperature-related intensity change (TRIC)-based high throughput screening platform for the discovery of CHI3L1-targeted small molecules14
Single-plate kinome screening in live-cells to enable highly cost-efficient kinase inhibitor profiling14
Label-free high-throughput screening via acoustic ejection mass spectrometry put into practice13
FocA: A deep learning tool for reliable, near-real-time imaging focus analysis in automated cell assay pipelines13
Patient derived glioma stem cell spheroid reporter assays for live cell high content analysis13
Screening for molecular glues – Challenges and opportunities12
In Memoriam12
Assay of Sphingosine 1-phosphate Transporter Spinster Homolog 2 (Spns2) Inhibitors12
Overcoming a false-positive mechanism in RapidFire MRM-based high throughput screening11
High-Throughput cell-based immunofluorescence assays against influenza11
High-throughput screening for the identification of dual inhibitors of BRD4 and RIPK3 toward the development of small-molecule medical countermeasure agents against arsenicals11
Comparative analysis of antibody-mediated loss-of-function versus gene knock-out and knock-down11
Protocol to develop A 3D tumor model for drug testing applications10
Highly scalable arrayed CRISPR mediated gene silencing in primary lung small airway epithelial cells10
Development of a live cell assay for the zinc transporter ZnT810
Bonferroni’s method, not Tukey’s, should be used to control the total number of false positives when making multiple pairwise comparisons in experiments with few replicates9
Identification of tau-tubulin kinase 1 inhibitors by microfluidics-based mobility shift assay from a kinase inhibitor library9
3D-Suspension culture platform for high throughput screening of neurotoxic chemicals using LUHMES dopaminergic neurons9
A perspective on the discovery of enzyme activators9
Corrigendum to “Varieties of Interactions of anti-CD133 Aptamers with Cell Cultures from Patient Glioblastoma” [SLAS Discov. 2024 Nov 16;29(8):100195]9
Automated high-throughput, high-content 3D imaging of intact pancreatic islets9
Development and validation of a generic methyltransferase enzymatic assay based on an SAH riboswitch9
An MRC-5 cell based high-throughput, high-content imaging assay to identify hits against Trypanosoma cruzi intracellular parasites9
A multiparametric calcium signal screening platform using iPSC-derived cortical neural spheroids.9
VOC analysis for rapid, early detection of bacteria, mold, and mycoplasma in cell and tissue cultures9
NF-kB oscillation profiles decode response to anti-EGFR monoclonal antibodies8
Using chemical and biological data to predict drug toxicity8
Creating a more strategic small molecule biophysical hit characterization workflow8
In Vitro three-dimensional (3D) cell culture tools for spheroid and organoid models7
Characterization of allosteric modulators that disrupt androgen receptor co-activator protein-protein interactions to alter transactivation–Drug leads for metastatic castration resistant prostate canc7
Temperature-related intensity change (TRIC)-based high-throughput screening enables the discovery of small molecule CD28 binders7
Binder2030: a quantitative membrane proteome binding dataset enabling AI-driven drug discovery7
Absolute quantification of Neuron-specific enolase based on surface plasmon resonance7
New homocysteine consumption assay for high-throughput screening of human cystathionine-β-synthase7
Publisher's Note7
A robust CETSA data analysis automation workflow for routine screening7
WITHDRAWN: Digital microfluidics as an emerging tool for bacterial protocols7
Protocol for kinetic mode potassium channel assays on common plate readers and microscopes7
Identification of novel inflammasome inhibitors via cellular NLRP3 target engagement assays7
Development of a high-throughput TR-FRET screening assay for a fast-cycling KRAS mutant7
A scalable human gut-immune co-culture model for evaluating inflammatory bowel disease anti-inflammatory therapies7
Protocol for high throughput 3D drug screening of patient derived melanoma and renal cell carcinoma7
An overview of drugging the bacterial cytoskeleton, rod, and divisome systems7
Novel high-content and open-source image analysis tools for profiling mitochondrial morphology in neurological cell models7
MSC.sensor: Capturing cancer cell interactions with stroma for functional profiling6
Towards Label-free detection of viral disease agents through their cell surface proteins: Rapid screening SARS-CoV-2 in biological specimens6
WITHDRAWN: Towards robotic laboratory automation Plug & play: Survey and concept proposal on teaching-free robot integration with the lapp digital twin6
High-throughput screening identifies non-nucleoside inhibitors of the SARS-CoV-2 polymerase with novel mechanisms6
A biochemical screening platform to target chromatin states using condensates as a tool6
Application of human iPSC-derived macrophages in a miniaturized high-content-imaging-based efferocytosis assay6
SARS-CoV-2 Mpro inhibitor identification using a cellular gain-of-signal assay for high-throughput screening6
Robustness of NanoBiT luciferase complementation technology in the presence of widely used kinase inhibitors6
Genome-scale functional genomics screening highlights genes impacting protein fucosylation in Chinese hamster ovary cells6
Protocols in drug discovery6
Combinatorial screen with apoptosis pathway targeted agents alrizomadlin, pelcitoclax, and dasminapant in multi-cell type tumor spheroids6
Characterisation of high throughput screening outputs for small molecule degrader discovery6
High throughput screening for drugs that inhibit 3C-like protease in SARS-CoV-25
Development of a time-resolved fluorescence resonance energy transfer ultra-high throughput screening assay targeting SYK and FCER1G interaction5
Differential analyte derivatization enables unbiased MALDI-TOF-based high-throughput screening: A proof-of-concept study for the discovery of catechol-o-methyltransferase inhibitors5
High throughput application of the NanoBiT Biochemical Assay for the discovery of selective inhibitors of the interaction of PI3K-p110α with KRAS5
Antimicrobial resistance: Linking molecular mechanisms to public health impact5
Open-source electrophilic fragment screening platform to identify chemical starting points for UCHL1 covalent inhibitors5
Development of a live cell assay for real-time monitoring the interactions between the Hippo pathway components 14-3-3 and TAZ5
Development of a cell-based target engagement assay for pyruvate dehydrogenase kinase5
High-throughput approaches to uncover synergistic drug combinations in leukemia5
Corelet™ platform: Precision high throughput screening for targeted drug discovery of biomolecular condensates5
Discovery and validation of small molecule stabilizers of mutant triose phosphate isomerase (TPI) as potential lead candidates for TPI deficiency5
A phenotypic screen for compounds that reverse cAMP-mediated suppression of T cell functions5
Adipocyte-based high throughput screening for anti-obesity drug discovery: Current status and future perspectives5
Drug discovery efforts at George Mason University4
Discovery of hit compounds for methyl-lysine reader proteins from a target class DNA-encoded library4
Graph neural networks for the identification of novel inhibitors of a small RNA4
Automated quality control tool for high-content imaging data by building 2D prediction intervals on reference biosignatures4
Optimized scaffold-free human 3D adipose tissue organoid culture for obesity and disease modeling4
Identification of unique binding mode anti-NTF3 antibodies from a novel long VH CDR3 phage display library4
Advancing the development of TRIP13 inhibitors: A high-throughput screening approach4
Validation, optimization, and quality assessment of a neuro-behavioral in vivo assay for phenotypic high-content evaluation of anesthetics4
PCIM: Learning pixel attributions via pixel-wise channel isolation mixing in high content imaging4
Grouping concentration response curves by features of their shape to aid rapid and consistent analysis of large data sets in high throughput screens4
Development of a high-throughput TR-FRET screening assay for LAG-3/FGL1 interaction4
Optimization and calibration of 384-well kinetic Ca2+ mobilization assays for the human transient receptor potential cation channels TRPM8, TRPV1, and TRPA14
Point-of-use, automated fabrication of a 3D human liver model supplemented with human adipose microvessels4
Alternate dyes for image-based profiling assays4
Compound management in a virtual research organization: The cornerstone of a reliable MMV discovery engine4
Optimising cell-based bioassays via integrated design of experiments (ixDoE) - A practical guide4
Enhancing throughput and robustness of the fibroblast to myofibroblast transition assay4
A high throughput assay for phosphoribosylformylglycinamidine synthase4
A multi-parametric high throughput assay for detecting beta-cell proliferation in dispersed primary islets4
Orthogonal temperature-related intensity change (TRIC) and TR-FRET as a high-throughput screening platform for the discovery of SLIT2 binders: A proof-of-concept approach4
Combinatorial screen of targeted agents with the PI3K inhibitors inavolisib, alpelisib, duvelisib, and copanlisib in multi-cell type tumor spheroids3
A mechanism of action-reflective, dual cell-based bioassay for determining the bioactivity of sclerostin-neutralizing antibodies3
HTS discovery of PARP1-HPF1 complex inhibitors in cancer3
1st EU-OPENSCREEN/SLAS data mining competition to predict compounds solubility3
Micro/nano topological modification of TiO2 nanotubes activates Thy-1 signaling to control osteogenic differentiation of stem cells3
Development of a BRET based chloride biosensor for high throughput screening of KCC2 modulators3
The role of m6A in lipid metabolism-related diseases3
The openOCHEM consensus model is the best-performing open-source predictive model in the First EUOS/SLAS joint compound solubility challenge3
High-throughput method to analyze the cytotoxicity of CAR-T Cells in a 3D tumor spheroid model using image cytometry3
Identification of chemicals breaking the USP8 interaction with its endocytic substrate CHMP1B3
Toxicity evaluation of pharmaceutical drugs and quantum dots (QDs) using zebrafish embryos – A comprehensive review3
High throughput screening for SARS-CoV-2 inhibitors targeting 5 helix bundle3
ATPase activity profiling of three human DExD/H-box RNA helicases3
Structure-activity relationships of thiadiazole agonists of the human secretin receptor3
Profiling oncogenic KRAS mutant drugs with a cell-based Lumit p-ERK immunoassay3
Mathematical relationships between control group variability and assay quality metrics3
Simultaneous screening for selective SARS-CoV-2, Lassa, and Machupo virus entry inhibitors3
Corrigendum to “Automation of high-throughput mRNA-seq library preparation: a robust, hands-free and time efficient methodology” [SLAS Discovery, Volume 27 (2022) P140-147/2472-5552]3
Magnetic three-dimensional bioprinting protocol for salivary gland mucoepidermoid carcinoma tumoroid culture3
WITHDRAWN: Detection and impact of hypoxic regions in multicellular tumor spheroid cultures formed by head and neck squamous cell carcinoma cells lines3
Green chemistry: Modern therapies using nanocarriers for treating rare brain cancer metastasis from colon cancer3
BRET measurement on CCD camera-based microtiter plate readers3
High throughput screening for compounds to the orphan nuclear receptor NR2F63
A novel high-throughput screening strategy for targeting alpha-synuclein and other long-lived proteins3
High-content phenotypic screen to identify small molecule enhancers of Parkin-dependent ubiquitination and mitophagy3
Establishment, optimization and validation of a fluorescence polarization-based high-throughput screening assay targeting cathepsin L inhibitors3
Streamlining cellular thermal shift assay for ultra-high throughput screening3
MT1G activation in dopaminergic neurons identifies chelators and their relationships to cytotoxicity3
Beyond fluorescence: A critical look at AI-powered brightfield analysis for T-cell killing assays3
0.071033954620361